Plante Moran Financial Advisors’s Harmony Biosciences HRMY Stock Holding History

Plante Moran Financial Advisors’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$255	Buy	+7	New	+$221	﹤0.01%	1365

Other funds holding HRMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

TCM

Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return

Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Plante Moran Financial Advisors's HRMY Position: Q2 2026 in Review

Plante Moran Financial Advisors opened a new position in Harmony Biosciences (HRMY) in Q2 2026: 7 shares worth $255. The stake represents ﹤0.01% of the portfolio and ranks #1365 among its holdings.

131 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

Plante Moran Financial Advisors held 7 shares of Harmony Biosciences worth $255 as of Q2 2026.
Harmony Biosciences was a new Plante Moran Financial Advisors position in Q2 2026.
Harmony Biosciences made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #1365 holding.
131 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.